(1197) Guillain-Barré Syndrome after Mrna-1273 Covid-19 Vaccine Booster in an Immunosuppressed Double Lung Transplant Recipient

INTRODUCTION: Guillain-Barré Syndrome (GBS) is an immune-mediated neurological disorder with an estimated incidence of 1 to 2 per 100,000 person-years. GBS is characterized by progressive and symmetric ascending muscle weakness, areflexia, sensory symptoms, and dysautonomia. Antecedent infection or...

Descripción completa

Detalles Bibliográficos
Autores principales: Sindu, D., Arjuna, A., Mcannally, K., Buddhdev, B., Walia, R., Mohamed, H., Abdelrazek, H., Omar, A., Tokman, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068073/
http://dx.doi.org/10.1016/j.healun.2023.02.1408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068073/
http://dx.doi.org/10.1016/j.healun.2023.02.1408

Ejemplares similares